TY - JOUR
T1 - Individual supported work placements (ReISE) for improving sustained return to work in unemployed people with persistent pain
T2 - study protocol for a cohort randomised controlled trial with embedded economic and process evaluations
AU - Amundsen, Pal Andre
AU - Underwood, Martin
AU - Burton, Kim
AU - Grotle, Margareth
AU - Malmberg-Helmonen, Ira
AU - Kisa, Adnan
AU - Cvancarova Smastuen, Milada
AU - Holmgard, Thor Einar
AU - Martinsen, Amy
AU - Lothe, Jakob
AU - Stahr Irgens, Pernille Marie
AU - Hojen, Magnus
AU - Spilde Monsen, Selvi
AU - Froud, Robert
N1 - Funding Information:
The funding for this trial was provided by the Norwegian Research Council through its Collaborative Project to meet Societal and Industry-related Challenges scheme (grant number 326732/ABHO) (Additional file ). The funder played no part in the study design and will play no part in the collection, management, analysis, and interpretation of the data; writing of the report; or the decision to submit the report for publication.
Funding Information:
RF is a director and shareholder of Clinvivo Ltd., which provides data collection in health services research studies. However, Clinvivo’s services were not used in this work and as such RF declared no conflicts of interest. MU is the chief investigator or co-investigator on multiple previous and current research grants from the UK National Institute for Health Research, Arthritis Research UK, and is a co-investigator on grants funded by the Australian NHMRC and Norwegian MRC. He was an NIHR senior investigator until March 2021. He has received travel expenses for speaking at conferences from the professional organisations hosting the conferences. He is a director and shareholder of Clinvivo Ltd. which provides electronic data collection for health services research. He is part of an academic partnership with Serco Ltd., funded by the European Social Fund, related to return-to-work initiatives. He receives some salary support from University Hospitals Coventry and Warwickshire. He is a co-investigator on two current and one completed NIHR-funded studies that are, of have had, additional support from Stryker Ltd. Until March 2020, he was an editor of the NIHR journal series and a member of the NIHR Journal Editors Group, for which he received a fee. All other authors declare that they have no competing interests.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/3/11
Y1 - 2023/3/11
N2 - Background: Around one-third of workdays lost in Norway are due to musculoskeletal conditions, with persistent (chronic) pain being the most frequent cause of sick leave and work disability. Increasing work participation for people with persistent pain improves their health, quality of life, and well-being and reduces poverty; however, it is not clear how to best help unemployed people who have persistent pain to return to work. The aim of this study is to examine if a matched work placement intervention featuring case manager support and work-focused healthcare improves return to work rates and quality of life for unemployed people in Norway with persistent pain who want to work. Methods: We will use a cohort randomised controlled approach to test the effectiveness and cost-effectiveness of a matched work placement intervention featuring case manager support and work-focused healthcare compared to those receiving usual care in the cohort alone. We will recruit people aged 18–64, who have been out of work for at least 1 month, had pain for more than 3 months, and want to work. Initially, all (n = 228) will be recruited to an observational cohort study on the impact of being unemployed with persistent pain. We will then randomly select one in three to be offered the intervention. The primary outcome of sustained return to work will be measured using registry and self-reported data, while secondary outcomes include self-reported levels of health-related quality of life and physical and mental health. Outcomes will be measured at baseline and 3, 6, and 12 months post-randomisation. We will run a process evaluation parallel to the intervention exploring implementation, continuity of the intervention, reasons for participating, declining participation, and mechanisms behind cases of sustained return to work. An economic evaluation of the trial process will also be conducted. Discussion: The ReISE intervention is designed to increase work participation for people with persistent pain. The intervention has the potential to improve work ability by collaboratively navigating obstacles to working. If successful, the intervention may be a viable option for helping people in this population. Trial registration: ISRCTN Registry 85,437,524 Registered on 30 March 2022.
AB - Background: Around one-third of workdays lost in Norway are due to musculoskeletal conditions, with persistent (chronic) pain being the most frequent cause of sick leave and work disability. Increasing work participation for people with persistent pain improves their health, quality of life, and well-being and reduces poverty; however, it is not clear how to best help unemployed people who have persistent pain to return to work. The aim of this study is to examine if a matched work placement intervention featuring case manager support and work-focused healthcare improves return to work rates and quality of life for unemployed people in Norway with persistent pain who want to work. Methods: We will use a cohort randomised controlled approach to test the effectiveness and cost-effectiveness of a matched work placement intervention featuring case manager support and work-focused healthcare compared to those receiving usual care in the cohort alone. We will recruit people aged 18–64, who have been out of work for at least 1 month, had pain for more than 3 months, and want to work. Initially, all (n = 228) will be recruited to an observational cohort study on the impact of being unemployed with persistent pain. We will then randomly select one in three to be offered the intervention. The primary outcome of sustained return to work will be measured using registry and self-reported data, while secondary outcomes include self-reported levels of health-related quality of life and physical and mental health. Outcomes will be measured at baseline and 3, 6, and 12 months post-randomisation. We will run a process evaluation parallel to the intervention exploring implementation, continuity of the intervention, reasons for participating, declining participation, and mechanisms behind cases of sustained return to work. An economic evaluation of the trial process will also be conducted. Discussion: The ReISE intervention is designed to increase work participation for people with persistent pain. The intervention has the potential to improve work ability by collaboratively navigating obstacles to working. If successful, the intervention may be a viable option for helping people in this population. Trial registration: ISRCTN Registry 85,437,524 Registered on 30 March 2022.
KW - persistent pain
KW - quality of life
KW - supported employment
KW - vocational rehabilitation
KW - unemployment
KW - work disability
KW - return to work
KW - labour market participation
KW - cohort randomised approach
KW - case management
KW - Vocational rehabilitation
KW - Case management
KW - Persistent pain
KW - Unemployment
KW - Work disability
KW - Quality of life
KW - Cohort randomised approach
KW - Labour market participation
KW - Supported employment
KW - Return to work
UR - http://www.scopus.com/inward/record.url?scp=85149939359&partnerID=8YFLogxK
U2 - 10.1186/s13063-023-07211-5
DO - 10.1186/s13063-023-07211-5
M3 - Article
C2 - 36906593
VL - 24
JO - Trials
JF - Trials
SN - 1745-6215
IS - 1
M1 - 179
ER -